Annual report pursuant to Section 13 and 15(d)

Accounting for Share-Based Payments (Tables)

v3.22.1
Accounting for Share-Based Payments (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average assumptions used in the Black-Scholes option-pricing model and weighted-average grant date fair value for options granted in 2020 are as follows:
Grant Date
February 5, 2020 June 30, 2020
Weighted-average assumptions used:
Expected volatility 35.1  % 38.7  %
Dividend yield 1.79  % 1.89  %
Risk-free interest rate 1.66  % 0.64  %
Expected term, in years 10 10
Weighted-average grant date fair value $ 4.53  $ 2.59 
Schedule of Activity in the Company’s Stock Option Plans
A summary of activity for the 2011 Plan is as follows:
Weighted
Average
Exercise
Price
Options
Outstanding
Weighted
Average
Contractual
Term
(in years)
Intrinsic
Value of
Options
December 31, 2019 $ 14.26  55,468  3.8 $ 18,331 
Granted February 5, 2020 13.00  123,500 
Granted June 30, 2020 7.33  20,000 
Exercised —  — 
 Canceled, forfeited, or expired 13.14  (19,437)
December 31, 2020 $ 12.74  179,531  7.2 $ 9,402 
Exercised 12.71  (13,174)
Canceled, forfeited, or expired 13.33  (22,529)
December 31, 2021 $ 13.04  143,828  6.0 $ 487,011 
Exercisable options $ 13.05  129,163  5.8 $ 436,637 
     
Options expected to vest: Weighted
Average
Exercise
Price
Options
Outstanding
Weighted
Average
Contractual
Term
(in years)
Grant Date Fair Value
December 31, 2019 $ 16.01  3,723  5.1 $ 6.11 
Granted February 5, 2020 13.00  123,500  4.53 
Granted June 30, 2020 7.33  20,000  2.59 
Vested 13.24  (34,786) 4.68 
   Canceled, forfeited, or expired 13.14  (19,437) 4.62 
December 31, 2020 $ 11.78  93,000  9.2 $ 5.53 
Vested 10.83  (55,806) 3.72 
Canceled, forfeited, or expired 13.33  (22,529) 4.80 
December 31, 2021 $ 13.00  14,665  8.1 $ 4.99 
Schedule of Stock Options by Exercise Price Range
The following table summarizes information about stock options outstanding as of December 31, 2021:
Range of Exercise Prices Outstanding Stock Options Exercisable Stock Options
Shares Weighted Average Shares Weighted Average Exercise Price
Exercise Price Remaining Contractual Life in Years
$ 11.35  9,068  $ 11.35  0.1 9,068  $ 11.35 
13.70  12,370  13.70  1.1 12,370  13.70 
14.76  8,109  14.76  2.1 8,109  14.76 
16.01  18,447  16.01  3.1 18,447  16.01 
13.00  85,834  13.00  8.1 71,169  13.00 
$ 7.33  10,000  $ 7.33  8.5 10,000  $ 7.33 
  143,828      129,163   
Schedule of Stock Awards Plan Activity
A summary of plan activity for the 2015 Plan is as follows:
Shares Weighted Average
Grant Date Fair Value
Outstanding December 31, 2019 100,775  $ 13.28 
Granted February 5, 2020 45,418  13.00 
Granted November 10, 2020 50,000  5.65 
Vested (81,233) 12.87 
Forfeited (17,535) 13.11 
Outstanding December 31, 2020 97,425  $ 11.97 
Granted February 10, 2021 15,181  8.57 
Granted October 28, 2021 6,751  11.11 
Granted November 15, 2021 751  13.32 
Vested (64,398) 9.25 
Forfeited (12,129) 10.54 
Outstanding December 31, 2021 43,581  $ 9.82 
A summary of the status of our inducement stock awards as of December 31, 2021, and changes during fiscal 2021, were as follows:
Units Weighted-Average Grant Date Fair Value
Outstanding December 31, 2020 —  $ — 
Granted 53,696  6.35 
Vested (12,516) 2.35 
Forfeited/Canceled (10,324) 5.96 
Outstanding December 31, 2021 30,856  $ 8.11 
Schedule of Nonvested Performance- based Units Activity
A summary of the status of our performance-based restricted stock awards as of December 31, 2021, and changes during fiscal 2021, were as follows:
Units Weighted-Average Grant Date Fair Value
Outstanding December 31, 2019 77,986  $ 13.66 
Granted1
36,647  13.00 
Vested2
(64,711) 13.21 
Forfeited (20,558) 13.73 
Outstanding December 31, 2020 29,364  $ 13.76 
Granted3
90,000  0.69 
Vested (116,260) 3.66 
Forfeited (3,104) 12.99 
Outstanding December 31, 2021 —  $ — 
1 Contingent shares granted excluded from 2020
2 Excludes the vesting of an additional 5,074 shares due to performance conditions of the awards exceeding target.
3 Contingent shares granted in prior year included in 2021